Reducing false positive diagnoses in mild cognitive impairment: the importance of comprehensive neuropsychological

S Z Klekociuk1, J J Summers, J C Vickers

  • 1School of Medicine, University of Tasmania, Launceston, Tasmania, Australia.

Abstract

Insights

New neuropsychological tests improve mild cognitive impairment (MCI) diagnosis by accurately identifying true cases. This reduces false positive diagnoses, enhancing diagnostic accuracy for memory and attention impairments.

Area of Science:

  • Neuroscience
  • Cognitive Psychology
  • Clinical Neurology

Background:

  • Longitudinal studies reveal significant recovery rates in mild cognitive impairment (MCI) cases.
  • Current MCI diagnostic criteria exhibit high false positive rates, indicating insufficient sensitivity and specificity.

Purpose of the Study:

  • To identify neuropsychological measures that distinguish true MCI cases from individuals who are unimpaired at follow-up.
  • To improve the accuracy of MCI diagnosis and reduce misclassification.

Main Methods:

  • Discriminant function analysis was employed to evaluate a battery of neuropsychological tests.
  • Participants were assessed over an 11-month follow-up period.

Main Results:

  • A combination of attention and memory measures achieved over 80% correct classification of outcomes.
  • The study identified a false positive rate of 5.93%, substantially lower than previously reported.

Conclusions:

  • Utilizing sensitive and specific neuropsychological assessments for memory and non-memory functions can significantly decrease false positive MCI diagnoses.
  • Improved diagnostic tools are crucial for accurate identification and management of MCI.